Paired associate learning in children with neurofibromatosis type 1: implications for clinical trials.
about
Behavioral and cognitive outcomes for clinical trials in children with neurofibromatosis type 1Modeling cognitive dysfunction in neurofibromatosis-1Randomized placebo-controlled study of lovastatin in children with neurofibromatosis type 1.Cognitive and Behavioral Disorders in Children with Neurofibromatosis Type 1.Social functioning and facial expression recognition in children with neurofibromatosis type 1.Cognition in children with neurofibromatosis type 1: data from a population-based study
P2860
Paired associate learning in children with neurofibromatosis type 1: implications for clinical trials.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Paired associate learning in c ...... lications for clinical trials.
@en
Paired associate learning in c ...... lications for clinical trials.
@nl
type
label
Paired associate learning in c ...... lications for clinical trials.
@en
Paired associate learning in c ...... lications for clinical trials.
@nl
prefLabel
Paired associate learning in c ...... lications for clinical trials.
@en
Paired associate learning in c ...... lications for clinical trials.
@nl
P2860
P50
P1433
P1476
Paired associate learning in c ...... plications for clinical trials
@en
P2093
Belinda Barton
P2860
P2888
P304
P356
10.1007/S00415-012-6620-5
P577
2012-08-09T00:00:00Z